Cedar Brook Financial Partners, LLC - GLAXOSMITHKLINE PLC ownership

GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 812 filers reported holding GLAXOSMITHKLINE PLC in Q1 2020. The put-call ratio across all filers is 0.66 and the average weighting 0.3%.

Quarter-by-quarter ownership
Cedar Brook Financial Partners, LLC ownership history of GLAXOSMITHKLINE PLC
ValueSharesWeighting
Q3 2020$245,000
-7.5%
6,4970.0%0.10%
-18.6%
Q2 2020$265,000
+8.6%
6,497
+0.7%
0.12%
-13.2%
Q1 2020$244,000
-19.7%
6,452
-0.2%
0.14%
+5.4%
Q4 2019$304,000
+10.5%
6,463
+0.5%
0.13%
+6.6%
Q3 2019$275,000
+5.4%
6,433
-1.3%
0.12%
+0.8%
Q2 2019$261,000
-4.0%
6,516
-0.0%
0.12%
-9.1%
Q1 2019$272,000
+8.4%
6,519
-0.7%
0.13%
-13.2%
Q4 2018$251,0006,5630.15%
Other shareholders
GLAXOSMITHKLINE PLC shareholders Q1 2020
NameSharesValueWeighting ↓
Sio Capital Management, LLC 325,823$11,557,0006.52%
KAHN BROTHERS GROUP INC 1,139,163$40,406,111,0006.35%
Chubb Ltd 400,000$14,188,0006.18%
Healthcare Value Capital, LLC 50,000$1,774,0005.40%
CLARK ESTATES INC/NY 650,000$23,056,0003.81%
PVG ASSET MANAGEMENT CORP 220,450$7,819,361,0003.57%
Martin Capital Partners, LLC 88,195$3,128,0003.25%
Camber Capital Management LP 1,500,000$53,205,0002.60%
EQUITY INVESTMENT CORP 2,090,120$74,137,0002.47%
Keystone Financial Planning, Inc. 129,102$4,579,0002.44%
View complete list of GLAXOSMITHKLINE PLC shareholders